Riyadh — Mubasher: Lana Medical Company disclosed that its board of directors invited shareholders to participate in the Extraordinary General Assembly meeting (EGM) that is scheduled for 15 December 2026, according to a bourse disclosure.
The primary agenda item for the assembly is a vote to amend Article 8 of the company’s bylaws concerning management.
The proposed amendment seeks to reduce the number of board of directors’ seats from seven to six members, while the term of membership remains unchanged at four years.
The meeting will be valid if attended by shareholders representing at least two-thirds of the company's capital.
Electronic voting is scheduled to begin on 12 December and will remain open until the conclusion of the assembly.
Shareholders registered in the issuer’s registry at the Depository Center by the end of the trading session preceding the meeting are eligible to attend and vote.
The Ministry of Commerce has previously issued a letter of non-objection regarding the proposed statutory amendments.